Dermatology Medical News about Gadolinium

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gadolinium-Induced Nephrogenic Systemic Fibrosis Is Associated with Insoluble Gd Deposits in Tissues: In Vivo Transmetallation Confirmed by Microanalysis
Journal of Cutaneous Pathology, 07/15/09

Thakral C et al. - The demonstration of insoluble tissue deposits of Gd with co-associated elements clearly confirms in vivo transmetallation and dissociation of soluble Gd-chelates. Toxic Gd3+ may trigger fibrosis under permissive conditions, e.g., in renal insufficiency. Pathologists and clinicians need to be aware of this serious but preventable disease.

<< Previous
The Keratins of the Human Beard Hair Medulla: The Riddle in the...

Next >>
Skin hydration and transepidermal water loss in patients with a...

Gadolinium-Associated Nephrogenic Systemic Fibrosis
American Family Physician, 10/01/09 Relevance Score: 91%%

New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
PLoS ONE - Cardiovascular Disorders, 11/13/09 Relevance Score: 87%%

Delayed gadolinium-enhanced magnetic resonance imaging of hip joint cartilage in femoroacetabular impingement: Are pre- and postcontrast imaging both necessary
Magnetic Resonance in Medicine, 11/12/09 Relevance Score: 84%%

Normal Dynamic MRI Enhancement Patterns of the Upper Abdominal Organs: Gadoxetic Acid Compared With Gadobutrol
American Journal of Roentgenology, 11/06/09 Relevance Score: 84%%

The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial
Clinical Cancer Research, 10/19/09 Relevance Score: 83%%